[Federal Register: January 23, 2008 (Volume 73, Number 15)]
[Notices]               
[Page 3977-3978]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23ja08-54]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-08-05CZ]

 
Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Assessing the Diabetes Detection Initiative for Policy Decisions--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Type II diabetes is a chronic disease that affects more than 18 
million Americans, approximately 5 million of whom do not know that 
they have the disease. As the disease progresses, it often causes 
severe complications, including heart disease, blindness, lower 
extremity arterial disease, and kidney failure. American Indians, 
African Americans, Latino Americans, and some Asian Americans and 
Pacific Islanders are disproportionately affected by diabetes. 
Identifying persons who have undiagnosed diabetes and treating them 
could prevent or delay diabetes complications.
    In November 2003 the Diabetes Detection Initiative (DDI) was 
launched in 10 regional locations around the U.S. to identify a portion 
of the estimated 5 million people with undiagnosed Type II diabetes. 
The DDI was designed to refer persons at increased risk of Type II 
diabetes to diagnostic testing, and if appropriate, to follow-up 
treatment. Whether or not the DDI should be expanded to other 
communities depends on the health benefit and costs of the program. The 
CDC plans to conduct a one-year study to provide this critical 
information.
    The planned information collection will assess the resources used, 
the cost per case detected, and the perceived benefit of the DDI to 
patients. Information for the assessment will be obtained by conducting 
the following surveys: (1) A health clinic leadership survey will be 
completed by the clinic director or representative of each of the 43 
clinics that participated in the DDI. The survey will obtain 
information on all activities and resources used at the clinic level 
related to diabetes screening, detection, and outreach services. 
Approximately 30 of the 43 eligible clinics are expected to participate 
in the survey. (2) A patient survey will be administered to a sample of 
600 patients from the participating clinics. The survey will collect 
information about each patient's background and out-of-pocket medical 
and non-medical direct health care costs (e.g., co-payments, 
transportation costs, and the value of the patient's time associated 
with clinic visits). The DDI Patient Survey will include a computer-
assisted personal interview (CAPI) module to collect information about 
each patient's stated preferences with respect to diabetes screening 
options.
    The results of the study will also provide information needed for 
evaluating the long-term cost-effectiveness of screening for 
undiagnosed diabetes in the United States.
    There are no costs to the respondents other than their time. The 
total estimated annualized burden hours are 263.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                        Number of
                                                                          Number of     responses      Average
           Type of respondents                      Form name            respondents       per       burden (in
                                                                                       respondent      hours)
----------------------------------------------------------------------------------------------------------------
DDI Clinic Representatives...............  DDI Health Clinic                      30             1             1
                                            Leadership Survey.
Patients at DDI Clinics..................  Screening Questions for the         1,000             1          2/60
                                            DDI Patient Survey.
                                           DDI Patient Survey.........           600             1         20/60
----------------------------------------------------------------------------------------------------------------



[[Page 3978]]

    Dated: January 10, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E8-1016 Filed 1-22-08; 8:45 am]

BILLING CODE 4163-18-P